Implementing Safe, Compliant and Successful Direct-To-Patient (DTPt) Sampling Programs

Webcast

***Live: Wednesday, May 26, 2021 at 1pm EDT | 12pm CDT | 10am PDT*** Break down the barriers to running a high-performing Direct-To-Patient (DTPt) sampling program. If you’re a product manager, brand manager, product launch manager or sales manager, attending this webinar will provide you with a wealth of useful knowledge and actionable information. Join sample management experts Eric Johnson and John Oroho of J. Knipper & Company as they offer their guidance, information and insights. Often viewed as a time, cost and resource drain on an organization, they’ll explain how a well-run sampling program not only reduces time and cost, but also expands product reach and maximizes ROI. *** On demand until May 26, 2022**

Event Overview:
In driving optimum outcomes for the patients that they serve, today’s manufacturers and practitioners utilize samples to perform a central and vital role. The last year has proven, however, that samples dispensed only from a physician’s office can present a variety of challenges. Patient safety, logistics and expense are key examples of challenges presented by the pandemic. There is a significant amount of misinformation, confusion and concerns around Direct-To-Patient sampling. The purpose of this webcast is to provide up-to-date advice from industry compliance and logistics experts when evaluating the implementation of Direct-To-Patient sampling program.

Direct-To-Patient (DTPt) sampling is gaining momentum and being implemented by manufacturers today under FDA guidance. FDA guidelines are paramount but not the only factors needed to be considered. Adherence with state boards of pharmacy regulations must also be addressed as well as HIPAA compliance.

Providing timely, streamlined and cost-effective DTPt programs that put product samples in the hands of patients fulfills a patient need. For manufacturers, it’s the opportunity for empowering practitioners with the means to administer the right products to the patients who benefit from them the most.

For physicians, it’s the opportunity to provide access to the best regimens for their patients, while ensuring that prescribed products are well tolerated.

For patients, once properly diagnosed, it’s the opportunity for a more immediate and efficient path to treatment during the pandemic.

BE PART OF THIS VALUABLE, INFORMATIVE WEBCAST

The “Implementing Safe, Compliant and Successful Direct-To-Patient (DTPt) Sampling Programs” webcast will cover many of today’s most important topics, including FDA considerations, state boards of pharmacy regulations, HIPAA compliance, protecting your organization (indemnification), and implementation and rollout of DTPt programs.

If you’re a product manager, brand manager or a sales manager, attending this webcast will provide you with a wealth of useful knowledge and actionable information.

Join sample management experts John Oroho of Porzio Life Sciences and Eric Johnson of J. Knipper & Company as these two industry leaders discuss the considerations that need to be taken into account when determining whether a DTPt sampling program makes sense and the many ways it can benefit your organization.

Speakers: Eric Johnson, Chief Commercial Growth Officer, J. Knipper & Company

John Patrick Oroho, Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC

Time and Date:
Wednesday, May 26, 2021 at 1pm EDT | 12pm CDT | 10am PDT

On Demand Until May 26, 2022.

Sponsors: Knipper

Register: http://www.pharmaceuticalcommerce.com/pc_w/sampling